|
Vol. 35 Nº 2 |
Lat. Am. J. Pharm. 35 (2): 213-424 (2016) |
REGULAR ARTICLES |
|
|
Synthesis, Characterization and Pharmacodynamics Studies of a Co-Drug Containing Paracetamol and Ibuprofen *
JIN C., ZHOU J., FU H., ZOU P., SHU G., ZHANG W., LI W. & PENG G. (217)
|
|
|
|
Pharmacokinetic Study of Venlafaxine and its Metabolite O-Desmethyl-Venlafaxine in Rats by UPLC-MS/MS *
CAI J., ZHU L., JIANG X., LV W., LIAN Y. & ZOU H. (226)
|
|
|
|
Pharmacokinetic and Bioavailability Study of Alogliptin in Rat Plasma by UPLC-MS/MS *
CHEN H., XIA X., LI L., JIANG W., WANG Y., XIA H., WANG Z. & WANG Y. (233)
|
|
|
|
Development and Validation of a HPLC Method for the Estimation of Omeprazole in Human Plasma *
LOU J., YU L., LI J., LIU J., DING Q., CHEN W., SUN L. & ZHANG Y. (239)
|
|
|
|
Medical Students' Attitudes and Barriers Towards Collaboration with Clinical Pharmacists in the Western Region of Saudi Arabia *
AL-HADDAD M.S., ABDALLAH Q.M.A. & ELDALO A.S. (244)
|
|
|
|
Validation of UPLC-MS/MS Method for the Determination of Cefprozil in Human Plasma *
GAN D., XIA K., SHAN S., YU Y. & SHI X. (254)
|
|
|
|
A New Method for Synthesis of 99mTc-enorfloxacin: an Infection Imaging Agent *
SHAHZAD S., QADIR M.A., RASHEED R., AHMAD A., SHAFIQ M.I., AHMED M., NOREEN S., ALI A., SHAHZADI S.K., & JAVED M. (259)
|
|
|
|
An UPLC-MS/MS Method for Highly Selective and Sensitive Determination of Jiangxienone from Cordyceps jiangxiensis with Potent Antitumor Activity *
LIU Y., ZHONG J., & XIAO J. (265)
|
|
|
|
Formulation and In Vitro Evaluation of Lysozyme-Loaded PLGA Microspheres Fabricated by One-Step Electrospraying Method *
LIU H., XI J., GENG H., CHEN G., ZHU Y., SHI S., DONG Y. & CAO J. (274)
|
|
|
|
Selection of Cryoprotective Agent for Freeze Drying of Valsartan Solid Lipid Nanoparticles *
KUMAR L., REDDY M.S., VERMA R. & KOTESHWARA K.B. (284)
|
|
|
|
Safety Evaluation of Anti-Glioma Drug 6-Gingerol *
HUANG B. & CHEN H. (291)
|
|
|
|
Profiling of Cetyl Pyridinium Chloride in Marketed Formulations by Stability Indicating Green Planar Chromatographic Method *
HAQ N., SALEM-BEKHIT M.M., SIDDIQUI N.A., SHAKEEL F., BASUDAN O.A., ALAM P., ARIF M. & GAMBHIR D. (296)
|
|
|
|
Preparation and In Vitro-In Vivo Evaluation of Piroxicam Dermal Films *
AUDA S.H., EL-RASOUL S.A., ISSA S.A.M. & MAHROUS G.M. (305)
|
|
|
|
Solubilization and Intestinal Permeability Studies of Poloxamers in the Absence and Presence of Sodium Deoxycholate on a Poorly Water-Soluble Compound *
ZHOU J., DAI J., FU H., SHU G., PENG G., FAN G. & LIU M. (312)
|
|
|
|
Formulation and In Vivo Evaluation of Peg Loaded Flurbiprofen Solid Dispersions Systems *
YADAV B. & TANWAR Y.S. (320)
|
|
|
|
Synthesis, Characterization and Antioxidant Activity of the Cu(II) Metal Complex with 2-p- Hydroxy Benzoic-4- p-Tolyl Imino-5,7-two Hydroxy Benzopyran as a Ligand Derived from Apigenin *
LI H., WEN L., ZHONG X. & WU L. (330)
|
|
|
|
Enhanced Oral Bioavailability of Carvedilol by Supersaturable Self Emulsifying Drug Delivery System *
MADISHETTY V.K., BONTHA V.K. & RAO D S. (337)
|
|
|
|
Bio-Screening of New Series of β-Lactams with Spectroscopic Characterization *
ASHFAQ M., AHMED M.M., SHAHEEN S., TABASSUM R., & RIVERA G. (348)
|
|
|
|
Development, Characterization and In Vitro Skin Permeation Studies of Lornoxicam-Loaded Cubosomes (Novel Nanocarriers) versus Liposomes *
BADRAN M., AHMAD A., RAISH M. & MOHSIN K. (358)
|
|
|
|
Simultaneous Determination of Magnesium Isoglycyrrhizinate and Its Active Metabolite 18a- Glycyrrhetinic Acid in Rat Plasma by UPLC-MS-MS *
XING E., QU B., ZHAO Y., LIAO Q., CHEN X., HU B., PENG D. & WANG G. (366)
|
|
|
SHORT COMMUNICATIONS |
|
|
Frequency of Prescription of Enalapriland Risk Associated with Non-steroidal Anti-inflammatory Drugs *
ASCAR G.I., RUIZ DÍAZ A.D., SILVA G.B. & BERTOLDO P. (374)
|
|
|
|
The Regulation of Diabetes Treatment Drug Glimepiride (GMP) towards Phase II Drug-Metabolizing Enzymes *
LI Z. & YUE Q. (379)
|
|
|
|
In Silico Screening Ginkgolide Compounds from Ginkgo biloba Extract Injection to Affect Drug- Metabolzing Enzymes *
SUN H., LI X., LIANG Z. & WANG D. (383)
|
|
|
|
In Vitro Screening of 5 Herbal Ingredients towards Important Drug-Metabolizing Enzymes Involved in the Hydrolysis Metabolism of Anti-Colon Cancer Drug Irinotecan *
WANG Y., WANG M., WAN Y., GONG H. & LI L. (386)
|
|
|
|
Effect of Glycosylation on the Enzymatic Activity of Defibrase from Agkistrodon acutus *
LUO X., SUN J. & ZHANG Y. (391)
|
|
|
|
Mechanism Analysis for Atractylenolide II-Zidovudine Interaction *
YU M., XING S., BAI X., ZHANG X., WANG C., WANG A., KONG X. & BAI M. (395)
|
|
|
|
Antitumor Activities of Pyran-Annulated Heterocycles *
LIU F., WU Y., Li J. & ZHOU Y. (399)
|
|
|
|
Synthesis and In Vitro Evaluation of Antibacterial Activity of a Novel Ca(II) Coordination Polymer *
LI X. & CHEN H. (403)
|
|
|
|
Assessment of Therapeutic Drug Monitoring of Gentamicin *
ALAKHALI K.M. (407)
|
|
|
|
Altered Metabolic Behavior of Schisanhenol in Patients with Ischemic Stroke *
HAN C., CAO Y., YU J., LIU F., ZHANG Y., MOU X., SHAN L., ZHAO J., YANG X. & TIAN X. (411)
|
|
|
|
Biological activity, Molecular Docking Studies and Molecular Dynamics Simulations of 2,3,4,5- Tetrahydro-1H-pyrido[4,3-b] indoles as c-Met inhibitors *
YE L., WU J., YANG J., CHEN W., LUO Y. & ZHANG Y. (416)
|
|
|
|
Two Novel Pyran Annulated Heterocyclic Compounds for Inhibiting Growth of Human Osteosarcoma Cells *
LI C., GUO D., ZHAO J., ZHANG K., & NIE L. (421)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|